Free Trial

CVRx (CVRX) Competitors

CVRx logo
$6.83 -0.13 (-1.87%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$6.87 +0.04 (+0.64%)
As of 07/11/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVRX vs. CBLL, EMBC, BBNX, AVNS, BVS, KIDS, RXST, AXGN, BFLY, and SMLR

Should you be buying CVRx stock or one of its competitors? The main competitors of CVRx include CeriBell (CBLL), Embecta (EMBC), Beta Bionics (BBNX), AVANOS MEDICAL (AVNS), Bioventus (BVS), OrthoPediatrics (KIDS), RxSight (RXST), AxoGen (AXGN), Butterfly Network (BFLY), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

CVRx vs. Its Competitors

CVRx (NASDAQ:CVRX) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

CeriBell has a net margin of 0.00% compared to CVRx's net margin of -97.49%. CeriBell's return on equity of 0.00% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-97.49% -79.04% -42.37%
CeriBell N/A N/A N/A

In the previous week, CeriBell had 2 more articles in the media than CVRx. MarketBeat recorded 10 mentions for CeriBell and 8 mentions for CVRx. CVRx's average media sentiment score of 1.20 beat CeriBell's score of 0.34 indicating that CVRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVRx
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CeriBell
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

CeriBell has higher revenue and earnings than CVRx.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$51.29M3.47-$59.97M-$2.18-3.13
CeriBell$65.44M8.91-$40.46MN/AN/A

75.3% of CVRx shares are held by institutional investors. 13.9% of CVRx shares are held by company insiders. Comparatively, 20.1% of CeriBell shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CVRx presently has a consensus price target of $14.50, indicating a potential upside of 112.30%. CeriBell has a consensus price target of $32.14, indicating a potential upside of 99.27%. Given CVRx's higher probable upside, research analysts clearly believe CVRx is more favorable than CeriBell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.86
CeriBell
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

CeriBell beats CVRx on 10 of the 14 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVRX vs. The Competition

MetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$178.08M$6.73B$5.56B$9.11B
Dividend YieldN/A1.29%5.07%4.01%
P/E Ratio-3.1320.2921.2120.54
Price / Sales3.4765.26432.0899.78
Price / CashN/A20.3337.1257.67
Price / Book2.334.648.045.49
Net Income-$59.97M$174.76M$3.19B$250.45M
7 Day Performance3.80%-1.00%3.63%4.79%
1 Month Performance15.18%-1.49%4.06%7.68%
1 Year Performance-29.73%4.27%30.02%16.43%

CVRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVRX
CVRx
3.1057 of 5 stars
$6.83
-1.9%
$14.50
+112.3%
-19.7%$178.08M$51.29M-3.13160News Coverage
Positive News
Analyst Revision
CBLL
CeriBell
2.5897 of 5 stars
$17.20
-9.1%
$32.14
+86.9%
N/A$684.19M$65.44M0.00N/ANews Coverage
Insider Trade
EMBC
Embecta
4.7511 of 5 stars
$10.03
-2.8%
$19.33
+92.8%
-18.0%$603.13M$1.08B11.142,100News Coverage
Positive News
BBNX
Beta Bionics
N/A$13.40
-0.9%
$23.44
+75.0%
N/A$586.18M$65.12M0.00294Positive News
AVNS
AVANOS MEDICAL
2.5823 of 5 stars
$11.87
-3.9%
N/A-43.6%$571.11M$687.80M-1.422,227News Coverage
BVS
Bioventus
2.9813 of 5 stars
$6.82
-2.8%
$13.75
+101.6%
+5.9%$560.22M$567.70M-11.181,200News Coverage
KIDS
OrthoPediatrics
4.2915 of 5 stars
$21.24
-5.5%
$35.83
+68.7%
-34.0%$545.96M$204.73M-12.14200
RXST
RxSight
2.245 of 5 stars
$12.43
-4.8%
$37.90
+204.9%
-83.9%$530.31M$139.93M-18.55220Trending News
Analyst Forecast
AXGN
AxoGen
2.4839 of 5 stars
$11.36
+3.9%
$24.50
+115.7%
+42.7%$497.80M$187.34M-75.73450Positive News
High Trading Volume
BFLY
Butterfly Network
2.4985 of 5 stars
$1.89
-2.6%
$3.50
+85.2%
+56.7%$479.74M$82.06M-6.52460Positive News
Options Volume
SMLR
Semler Scientific
2.4215 of 5 stars
$38.95
-3.7%
$71.00
+82.3%
+35.4%$451.08M$56.29M-14.92120Analyst Forecast

Related Companies and Tools


This page (NASDAQ:CVRX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners